Researchers want their technology to be used by patients around the world, fulfilling an underlying driver for their work. A possible path to realize this goal involves commercialization of this technology via a major player in the market that can handle final development and distribution. This session will discuss what makes a particular technology attractive to a company. How is the unmet need being solved to address a market, with considerations, for example, of assessing fit into existing workflows, cost margins, and general risk reduction. 

Two invited speakers from large medical device companies will weigh in on what they look for during discovery - both internal and via acquisition. The presentations will be followed by a Q&A opportunity with additional panelists. 

Start-up companies fill a gap between early stage research and de-risked technology or a completed product. Founders must consider how to structure product development to achieve their goals in the time frame of the funding runway. Critical to this is defining the end game at the beginning - what does success look like to you as a founder? How are milestones and funding rounds planned to maximize likelihood of this success?

Two invited speakers will share their experiences. The presentations will be followed by a Q&A opportunity with additional panelists.